wire - news in brief


Results 51 - 100 of 353.

Life Sciences - Chemistry - 28.01.2019
How do mRNAs deal with stress?
Two hallmarks of the integrated stress response of cells are the inhibition of translation and the formation of stress granules (SGs) and processing bodies (PBs). However, it is not well understood how both processes are coupled. In a study published in Molecular Cell, researchers from the Chao group applied single-molecule RNA imaging to study the interactions of mRNAs with SGs and PBs, and found out that the generally accepted assumptions about the function of granules need to be revised.

Materials Science - Chemistry - 25.01.2019

Environment - 24.01.2019
Eawag at the 2019 World Economic Forum
Eawag at the 2019 World Economic Forum
A walk-through exhibition introduces people to innovative projects from various institutes.

Event - 24.01.2019

Innovation / Technology - Astronomy / Space Science - 23.01.2019

Pharmacology - Life Sciences - 22.01.2019

Environment - Chemistry - 22.01.2019
More energy-efficient cruise ships
More energy-efficient cruise ships
An EPFL researcher has developed a system based on fuel cells to reduce the carbon footprint and energy consumption of cruise ships, which are increasingly popular among vacation goers around the world.

Health - Life Sciences - 22.01.2019

Administration - Business / Economics - 21.01.2019

Life Sciences - 21.01.2019
Octopus's Garden: The Stunning Life of Macroalgae
Octopus’s Garden: The Stunning Life of Macroalgae
The Botanical Garden of the University of Zurich is displaying large-format pictures of macroalgae taken by photographer Josh Westrich, bringing these maritime organisms into the tropical setting of UZH's greenhouses.

Pharmacology - Health - 17.01.2019
FDA accepts Roche’s supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application (sBLA) for Tecentriq (atezolizumab) in combination with Abra

Environment - 15.01.2019
Carbon cycles as a yardstick for climate change
Carbon cycles as a yardstick for climate change
The study by 153 researchers from 40 countries found that climate factors such as temperature and humidity strongly influence the carbon cycles of river ecosystems.

Health - Materials Science - 15.01.2019
Ears from the 3D-printer
Ears from the 3D-printer
Cellulose obtained from wood has amazing material properties. Empa researchers are now equipping the biodegradable material with additional functionalities to produce implants for cartilage diseases using 3D printing.

Health - Life Sciences - 15.01.2019

Environment - Life Sciences - 15.01.2019
EPFL goes to New Zealand to study melting glaciers
Four EPFL researchers will explore New Zealand's glacier-fed streams for two months, marking the first step in a global journey that will take them across 15 countries by 2021.

Innovation / Technology - Business / Economics - 11.01.2019
EPFL drones draw crowds in Las Vegas
EPFL drones draw crowds in Las Vegas
This week, four EPFL-designed drones are being shown in the Swiss Pavilion at the Consumer ElectronicsShow in Las Vegas.

Innovation / Technology - 10.01.2019

Event - Business / Economics - 09.01.2019

Life Sciences - 09.01.2019
Change of Teeth Causes Yo-Yo Effect in Elephants' Weight
Change of Teeth Causes Yo-Yo Effect in Elephants’ Weight
The weight of elephants living in zoos fluctuates over the course of their adult lives in cycles lasting around a hundred months, researchers at the University of Zurich have found. The fluctuation is linked to the particular pattern of tooth change in elephants, which results in them having more or less chewing surface available.

Pharmacology - Health - 08.01.2019
Novartis investigational therapy crizanlizumab (SEG101) receives FDA Breakthrough Therapy designation for the prevention of vaso-occlusive crises in sickle cell disease
Crizanlizumab is a monthly infusion under development to prevent pain crises (also called vaso-occlusive crises, or VOCs) in patients with sickle cell disease Sickle cell VOCs, which are triggered

Pharmacology - Health - 07.01.2019
Sandoz and Pear Therapeutics Announce US Launch of reSET-OTM to Help Treat Opioid Use Disorder
ReSET-O(TM)* is the first US FDA-cleared prescription digital therapeutic for patients with Opioid Use Disorder Cleared by the FDA in December, reSET-O is available immediately As part of a broader f

Innovation / Technology - Careers / Employment - 07.01.2019
Eleven EPFL startups in Las Vegas
Eleven EPFL startups in Las Vegas
This week, eleven EPFL startups are in Las Vegas to tout their technologies at the Consumer Electronics Show, one of the largest events of its kind.

Innovation / Technology - Health - 04.01.2019

Life Sciences - Physics - 02.01.2019
Pushing the boundaries of the visible
Our cutting-edge technology platforms are key enablers of research at the FMI. One of the biggest of these, with the largest number of users, is the Facility for Advanced Imaging and Microscopy (FAIM). To find out more about the facility, and microscopy in general, we spoke to the joint heads of FAIM - Christel Genoud, who is responsible for Electron Microscopy, and Laurent Gelman, responsible for Light Microscopy.

Health - Pharmacology - 21.12.2018
Novartis receives European Commission (EC) approval for expanded indication for Kisqali (ribociclib)
Basel, December 21, 2018 - Novartis today announced that the European Commission (EC) approved an expanded indication for Kisqali (ribociclib), the CDK4/6 inhibitor with the largest body of first-li

Innovation / Technology - Careers / Employment - 21.12.2018

Astronomy / Space Science - 20.12.2018

Pharmacology - Health - 20.12.2018
Novartis announces offer to acquire CellforCure to expand manufacturing capacity for innovative cell and gene therapies
Proposed acquisition builds on existing agreement with CellforCure for contract manufacturing of Novartis leading CAR-T cell therapy Kymriah (tisagenlecleucel) and recent successful completion of tec

Pharmacology - Business / Economics - 20.12.2018

Business / Economics - Innovation / Technology - 19.12.2018

Careers / Employment - 18.12.2018

Environment - 17.12.2018
Preserving soil quality in the long term
Preserving soil quality in the long term
The National Research Programme "Sustainable Use of Soil Resources" (NRP 68) proposes various measures to safeguard soil quality in Switzerland in the long term. The Centre for Development and Environment (CDE) and the Institute of Geography have investigated the impacts of soil use by Switzerland abroad.

Chemistry - 17.12.2018

Health - Pharmacology - 17.12.2018
PRIME designation granted by European Medicines Agency for Roche’s risdiplam for treatment of spinal muscular atrophy (SMA)
PRIME designation granted by European Medicines Agency for Roche's risdiplam for treatment of spinal muscular atrophy (SMA) Risdiplam has the potential to be the first oral medicine for the treatment

Environment - Health - 14.12.2018

Materials Science - Administration - 14.12.2018

Business / Economics - Computer Science / Telecom - 13.12.2018